Dioralyte Rebalance Blackcurrant Powder for Oral Solution.

Product Information *

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 13 May 2021

File name

Dioralyte Rebalance patient leaflet IE1160 cropped_1620924193.pdf

Reasons for updating

  • Change to section 2 - use in children and adolescents
  • Change to section 3 - dose and frequency
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 3 - duration of treatment
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 13 May 2021

File name

1.3.1 SmPC Dioralyte Rebalance Blackcurrant_1620923842.pdf

Reasons for updating

  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Updated on 19 March 2020

File name

1.3.1 SmPC Dioralyte Rebalance Blackcurrant_1584634859.pdf

Reasons for updating

  • New SPC for new product

Legal category:Supply through pharmacy only

Updated on 19 March 2020

File name

Dioralyte Rebalance PL 419521_1584634841.pdf

Reasons for updating

  • New PIL for new product